pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioPharma Dive·Jul 14·1 min read
save

Cayman court orders Apple Tree Partners’ general partner to give up control of venture fund

Jul 14, 2026·read at BioPharma Dive ↗RegulatoryNegative

A Cayman Islands court ruled that Seth Harrison, the general partner of biotech venture firm Apple Tree Partners, must relinquish oversight of the fund. The order could shift management to two court‑appointed independent directors from Alvarez & Marsal.

The appointed directors, Alexander Lawson and Barry Lynch, are expected to assume control of the fund’s operations, removing Harrison from day‑to‑day decision making.

The ruling comes amid a broader legal battle that includes a separate U.S. bankruptcy proceeding. Apple Tree Partners is pursuing a restructuring plan to keep financing its portfolio companies, and Harrison has positioned himself as a bidder for those startups.

The dispute traces back to 2012 when a family trust linked to Russian billionaire Dmitry Rybolovlev agreed to fund up to $1.5 billion of Apple Tree’s biotech investments, a relationship that has become entangled in the current litigation.

source

This writeup was produced by pharmadog from original reporting by BioPharma Dive.

Original headline: “Judge orders Apple Tree partner to forfeit oversight of venture fund”

read at BioPharma Dive ↗
589 words · retrieved Jul 14
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Akero Therapeutics IncRed Queen Therapeutics Inc

related stories

  • Aug 5A COPD drug from China draws $115M in venture fundingBioPharma Dive
  • Jul 14Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pillBioPharma Dive
  • Jul 14STAT+: Akero team, backed by Fairmount, launches new immunology companySTAT
  • Jul 14Former Akero team announces new I&I company, Avere, with China drugEndpoints